JPH043397B2 - - Google Patents

Info

Publication number
JPH043397B2
JPH043397B2 JP59264106A JP26410684A JPH043397B2 JP H043397 B2 JPH043397 B2 JP H043397B2 JP 59264106 A JP59264106 A JP 59264106A JP 26410684 A JP26410684 A JP 26410684A JP H043397 B2 JPH043397 B2 JP H043397B2
Authority
JP
Japan
Prior art keywords
group
lower alkyl
phenyl
alkyl group
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59264106A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60142979A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS60142979A publication Critical patent/JPS60142979A/ja
Publication of JPH043397B2 publication Critical patent/JPH043397B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP59264106A 1983-12-14 1984-12-13 １，５‐ベンゾオキサチエピン誘導体 Granted JPS60142979A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1983/000436 WO1985002617A1 (fr) 1983-12-14 1983-12-14 Derives de 1,5-benzoxathiepine et leur procede de preparation
MC83/436 1983-12-14
MC84/168 1984-04-04
MC84/526 1984-11-01

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP1032375A Division JPH02191271A (ja) 1983-12-14 1989-02-10 １，５―ベンゾオキサチエピン誘導体
JP1032376A Division JPH02191272A (ja) 1983-12-14 1989-02-10 １，５―ベンゾオキサチエピン誘導体

Publications (2)

Publication Number Publication Date
JPS60142979A JPS60142979A (ja) 1985-07-29
JPH043397B2 true JPH043397B2 (enExample) 1992-01-23

Family

ID=13790100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59264106A Granted JPS60142979A (ja) 1983-12-14 1984-12-13 １，５‐ベンゾオキサチエピン誘導体

Country Status (4)

Country Link
JP (1) JPS60142979A (enExample)
SU (1) SU1438611A3 (enExample)
WO (1) WO1985002617A1 (enExample)
ZA (1) ZA849718B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229467A1 (en) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin derivatives, their production and use
FR2908132B1 (fr) * 2006-11-08 2008-12-19 Pierre Fabre Medicament Sa Procede de synthese du n-[3-[(2-methoxyphenyl)sulfanyl]-2- methylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf

Also Published As

Publication number Publication date
SU1438611A3 (ru) 1988-11-15
WO1985002617A1 (fr) 1985-06-20
JPS60142979A (ja) 1985-07-29
ZA849718B (en) 1986-08-27

Similar Documents

Publication Publication Date Title
JP4316794B2 (ja) イソキノリン誘導体及び医薬
JPH08506576A (ja) 低脂血症化合物
JPWO1999020620A1 (ja) イソキノリン誘導体及び医薬
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
JPS6136273A (ja) ２−フエニルアルキル−４（３ｈ）−キナゾリノン誘導体
JPH0560831B1 (enExample)
JPH045673B2 (enExample)
JPH07100688B2 (ja) 環状アミン誘導体
JPH043397B2 (enExample)
JPH0374221B2 (enExample)
PT719766E (pt) Derivado 1,4-benzoxazina composicao farmaceutica contendo o mesmo e sua utilizacao
JPH0625186B2 (ja) ２−アリ−ルベンゾチアジン誘導体
JPH0684361B2 (ja) １，５―ベンゾチアゼピン誘導体、その製法及びその合成中間体
JP3748935B2 (ja) オキシインドール誘導体
JPH10310576A (ja) イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬
KR100254106B1 (ko) 4-퀴놀리논 유도체 또는 그의 염
JPWO1995033726A1 (ja) ４−キノリノン誘導体又はその塩
JP4011780B2 (ja) ジヒドロキノリン誘導体
JP2559596B2 (ja) オキサゾリン誘導体
JPH0764840B2 (ja) 縮合ヘテロ７員環化合物
JPH03197463A (ja) 新規ベンズアゼピン
JPH10152481A (ja) ベンゾ［１，４］チアジン誘導体およびそれからなる医薬
JPH11500754A (ja) 新規化合物および多発性硬化症の処置法
KR100248329B1 (ko) 신규한 제니핀 유도체 및 이를 유효성분으로 하는 간질환치료제조성물
WO1986002644A1 (fr) Derives de 1,5-benzoxathiepines et leur procede de preparation